Erratum

Article

An article authored by Josef Reiter, MD, titled "My way to Epi-LASIK", which appeared in the July/August issue of Ophthalmology Times Europe, contained an error on page 20.

An article authored by Josef Reiter, MD, titled “My way to Epi-LASIK”, which appeared in the July/August issue of Ophthalmology Times Europe, contained an error on page 20. A portion of the sentence appearing beneath the sidebar “Current Epi-LASIK medication regimen” was missing from the printed article. This should read as follows: Uncorrected and best-corrected visual acuity was initially a little better without the flap, about the same in both groups at one month, and slightly better in the flap group by three months (Figure 6).

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
Related Content
© 2024 MJH Life Sciences

All rights reserved.